{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:40:12Z","timestamp":1774312812264,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s00117-021-00926-z","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:32:43Z","timestamp":1634599963000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiples Myelom aus Sicht der Pathologie","Multiple myeloma from the pathologist\u2019s perspective"],"prefix":"10.1007","volume":"62","author":[{"given":"Antonio","family":"Vogelsberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Sch\u00fcrch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-pathol-011110-130249","volume":"6","author":"KC Anderson","year":"2011","unstructured":"Anderson\u00a0KC, Carrasco\u00a0RD (2011) Pathogenesis of myeloma. Annu Rev Pathol 6:249\u2013274","journal-title":"Annu Rev Pathol"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ejrad.2014.03.005","volume":"83","author":"M Andrulis","year":"2014","unstructured":"Andrulis\u00a0M, B\u00e4uerle\u00a0T, Goldschmidt\u00a0H et\u00a0al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970\u2013974","journal-title":"Eur J Radiol"},{"key":"926_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01121","author":"BG Barwick","year":"2019","unstructured":"Barwick BG, Gupta VA, Vertino PM et al (2019) Cell of origin and genetic alterations in the pathogenesis of multiple myeloma. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01121","journal-title":"Front Immunol"},{"issue":"Suppl 1","key":"926_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/hon.2065","volume":"31","author":"PL Bergsagel","year":"2013","unstructured":"Bergsagel\u00a0PL, Chesi\u00a0M (2013) V. Molecular classification and risk stratification of myeloma. Hematol Oncol 31(Suppl 1):38\u201341","journal-title":"Hematol Oncol"},{"key":"926_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12534","author":"SS Chawla","year":"2015","unstructured":"Chawla SS, Kumar SK, Dispenzieri A et al (2015) Clinical course and prognosis of non-secretory multiple myeloma. Eur J Haematol. https:\/\/doi.org\/10.1111\/ejh.12534","journal-title":"Eur J Haematol."},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","volume":"132","author":"J-P Fermand","year":"2018","unstructured":"Fermand\u00a0J\u2011P, Bridoux\u00a0F, Dispenzieri\u00a0A et al (2018) Monoclonal gammopathy of clinical significance: a\u00a0novel concept with therapeutic implications. Blood 132:1478\u20131485","journal-title":"Blood"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1016\/j.clml.2020.05.026","volume":"20","author":"M Ho","year":"2020","unstructured":"Ho\u00a0M, Goh\u00a0CY, Patel\u00a0A et\u00a0al (2020) Role of the bone marrow milieu in multiple myeloma progression and therapeutic resistance. Clin Lymphoma Myeloma Leuk 20:e752\u2013e768","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1038\/s41375-020-01051-x","volume":"34","author":"M Ho","year":"2020","unstructured":"Ho\u00a0M, Patel\u00a0A, Goh\u00a0CY et\u00a0al (2020) Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Leukemia 34:3111\u20133125","journal-title":"Leukemia"},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","volume":"263","author":"Y Kawano","year":"2015","unstructured":"Kawano\u00a0Y, Moschetta\u00a0M, Manier\u00a0S et\u00a0al (2015) Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev 263:160\u2013172","journal-title":"Immunol Rev"},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1172\/JCI61188","volume":"122","author":"WM Kuehl","year":"2012","unstructured":"Kuehl\u00a0WM, Bergsagel\u00a0PL (2012) Molecular pathogenesis of multiple myeloma and its premalignant precursor. J\u00a0Clin Invest 122:3456\u20133463","journal-title":"J Clin Invest"},{"key":"926_CR11","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF Diagnostik, Therapie und Nachsorge f\u00fcr Patienten mit monoklonaler Gammopathie unklarer Signifikanz (MGUS) oder Multiplen Myelom, Langversion 1.01 (Konsultationsfassung, 2021, AWMF Registernummer: 018\/035OL. https:\/\/www.Leitlinienprogramm-Onkologie.De\/Leitlinien\/Multiples-Myelom\/. Zugegriffen: 12. Sept. 2021"},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41581-018-0077-4","volume":"15","author":"N Leung","year":"2019","unstructured":"Leung\u00a0N, Bridoux\u00a0F, Batuman\u00a0V et\u00a0al (2019) The evaluation of monoclonal gammopathy of renal significance: a\u00a0consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nat Rev Nephrol 15:45\u201359","journal-title":"Nat Rev Nephrol"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","volume":"88","author":"JR Mikhael","year":"2013","unstructured":"Mikhael\u00a0JR, Dingli\u00a0D, Roy\u00a0V et al (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88:360\u2013376","journal-title":"Mayo Clin Proc"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/leu.2016.366","volume":"31","author":"S Mithraprabhu","year":"2017","unstructured":"Mithraprabhu\u00a0S, Khong\u00a0T, Ramachandran\u00a0M et\u00a0al (2017) Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma. Leukemia 31:1695\u20131705","journal-title":"Leukemia"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo\u00a0A, Avet-Loiseau\u00a0H, Oliva\u00a0S et al (2015) Revised international staging system for multiple myeloma: a report from international myeloma working group. J\u00a0Clin Oncol 33:2863\u20132869","journal-title":"J Clin Oncol"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn\u00a0C, Morgan\u00a0GJ (2017) Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer 17:543\u2013556","journal-title":"Nat Rev Cancer"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1200\/JCO.18.00776","volume":"37","author":"A Perrot","year":"2019","unstructured":"Perrot\u00a0A, Lauwers-Cances\u00a0V, Tournay\u00a0E et al (2019) Development and validation of a\u00a0cytogenetic prognostic index predicting survival in multiple myeloma. J\u00a0Clin Oncol 37:1657\u20131665","journal-title":"J Clin Oncol"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar\u00a0SV, Dimopoulos\u00a0MA, Palumbo\u00a0A et\u00a0al (2014) International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538\u2013e548","journal-title":"Lancet Oncol"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1182\/blood-2018-04-842880","volume":"132","author":"L Rasche","year":"2018","unstructured":"Rasche\u00a0L, Angtuaco\u00a0EJ, Alpe\u00a0TL et\u00a0al (2018) The presence of large focal lesions is a\u00a0strong independent prognostic factor in multiple myeloma. Blood 132:59\u201366","journal-title":"Blood"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","volume":"8","author":"L Rasche","year":"2017","unstructured":"Rasche\u00a0L, Chavan\u00a0SS, Stephens\u00a0OW et al (2017) Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing. Nat Commun 8:268","journal-title":"Nat Commun"},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/bjh.17338","volume":"194","author":"L Rosi\u00f1ol","year":"2021","unstructured":"Rosi\u00f1ol\u00a0L, Beksac\u00a0M, Zamagni\u00a0E et al (2021) Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations. Br J Haematol 194:496\u2013507","journal-title":"Br J Haematol"},{"key":"926_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-019-02725-3","author":"CM Sch\u00fcrch","year":"2019","unstructured":"Sch\u00fcrch CM, Rasche L, Frauenfeld L et\u00a0al (2019) A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-019-02725-3","journal-title":"Virchows Arch."},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1309\/5EL22BH45PHUPM8P","volume":"127","author":"AC Seegmiller","year":"2007","unstructured":"Seegmiller\u00a0AC, Xu\u00a0Y, Mckenna\u00a0RW et al (2007) Immunophenotypic differentiation between neoplastic plasma cells in mature B\u2011cell lymphoma vs plasma cell myeloma. Am J Clin Pathol 127:176\u2013181","journal-title":"Am J Clin Pathol"},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy Jr.","year":"2007","unstructured":"Shaughnessy\u00a0JD Jr., Zhan\u00a0F, Burington\u00a0BE et al (2007) A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 109:2276\u20132284","journal-title":"Blood"},{"key":"926_CR25","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"CE Swerdlow-Sh","year":"2017","unstructured":"Swerdlow-Sh\u00a0CE, Harris\u00a0N, Jaffe\u00a0E (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4.\u00a0Aufl. IARC, Lyon","edition":"4"},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","volume":"33","author":"BA Walker","year":"2015","unstructured":"Walker\u00a0BA, Boyle\u00a0EM, Wardell\u00a0CP et\u00a0al (2015) Mutational spectrum, copy number changes, and outcome: results of a\u00a0sequencing study of patients with newly diagnosed myeloma. J\u00a0Clin Oncol 33:3911\u20133920","journal-title":"J Clin Oncol"},{"key":"926_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1055\/s-2005-858362","volume":"177","author":"K Wasser","year":"2005","unstructured":"Wasser\u00a0K, Moehler\u00a0T, Nosas-Garcia\u00a0S et al (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. RoFo 177:1116\u20131122","journal-title":"RoFo"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00926-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-021-00926-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-021-00926-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:09:25Z","timestamp":1642514965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-021-00926-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s00117-021-00926-z","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"24 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Vogelsberg, C.M.\u00a0Sch\u00fcrch und F.\u00a0Fend geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}